MRKR - Marker Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRKR is currently covered by 1 analysts with an average price target of $23.11. This is a potential upside of $22.1 (2188.12%) from yesterday's end of day stock price of $1.01.

Marker Therapeutics's activity chart (see below) currently has 12 price targets and 14 ratings on display. The stock rating distribution of MRKR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 6.25% with an average time for these price targets to be met of 1.75 days.

Highest price target for MRKR is $11, Lowest price target is $11, average price target is $11.

Most recent stock forecast was given by AYDIN HUSEYNOV from LADENBURG on 21-Oct-2024. First documented stock forecast 22-Oct-2018.

Best performing analysts who are covering MRKR - Marker Therapeutics:

Edward Tenthoff Matthew Biegler Joseph Catanzaro Aydin Huseynov

Currently out of the existing stock ratings of MRKR, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$10 (1000.00%)

$11

5 months 18 days ago
(21-Oct-2024)

0/2 (0%)

$7.3 (197.30%)

Buy

$15

$14 (1400.00%)

2 years 10 months 12 days ago
(27-May-2022)

0/1 (0%)

$12 (400.00%)

Buy

3 years 1 months 22 days ago
(17-Feb-2022)

0/1 (0%)

$67.7 (82.26%)

Buy

$25

4 years 14 days ago
(25-Mar-2021)

1/4 (25%)

$1.4 (5.93%)

7

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRKR (Marker Therapeutics) average time for price targets to be met?

On average it took 1.75 days on average for the stock forecasts to be realized with a an average price target met ratio 6.25

Which analyst has the current highest performing score on MRKR (Marker Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on MRKR (Marker Therapeutics) with a proven track record?

AYDIN HUSEYNOV

Which analyst has the most public recommendations on MRKR (Marker Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 4 ratings on MRKR

Which analyst is the currently most bullish on MRKR (Marker Therapeutics)?

Joseph Catanzaro with highest potential upside - $14

Which analyst is the currently most reserved on MRKR (Marker Therapeutics)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?